InflaRx (IFRX) Common Equity (2016 - 2026)
InflaRx (IFRX) posted Common Equity of $163.42 million for Q3 2026, up 207.1% from $53.22 million a year earlier but down 2.1% from the prior quarter.
Powered by 
Analysis
InflaRx (IFRX) Common Equity (2016 - 2026) Analysis & Trends
At the end of FY2025, InflaRx's Common Equity came in at $48.82 million, down 23.6% from FY2024.
- Annual Common Equity shows a five-year compound annual growth rate of -12.6% (FY2020 to FY2025).
- In prior years, InflaRx's Common Equity was $63.91 million in FY2024 (-43.7%), $113.54 million in FY2023 (+20.5%), $94.19 million in FY2022 (-21.0%) and $119.23 million in FY2021 (+24.5%).
- Quarterly Common Equity has run from a low of $42.28 million in Q1 2026 to a high of $166.97 million in Q2 2026 over five years.
- On a year-over-year basis, Common Equity increased in two of the last eight quarters, with growth averaging 21.0%.
- The strongest year-over-year quarter for Common Equity in the past five years was Q3 2026, with growth of 207.1%; the weakest was Q1 2026, with a decline of 44.6%.
- According to Business Quant data, Common Equity for the three prior quarters was $166.97 million (Q2 2026), $42.28 million (Q1 2026) and $48.82 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 89.30 Bn |
| 10 | InflaRx | 85.79 Mn | -160.38 Mn | - | 48.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 163.42 Mn |
| Jun 30, 2026 | 166.97 Mn |
| Mar 31, 2026 | 42.28 Mn |
| Dec 31, 2025 | 48.82 Mn |
| Sep 30, 2025 | 53.22 Mn |
| Jun 30, 2025 | 66.90 Mn |
| Mar 31, 2025 | 76.27 Mn |
| Dec 31, 2024 | 63.91 Mn |
| Sep 30, 2024 | 72.92 Mn |
| Jun 30, 2024 | 87.98 Mn |
| Mar 31, 2024 | 102.29 Mn |
| Dec 31, 2023 | 113.54 Mn |
| Sep 30, 2023 | 124.63 Mn |
| Jun 30, 2023 | 135.47 Mn |
| Mar 31, 2023 | 85.69 Mn |
| Dec 31, 2022 | 94.19 Mn |
| Sep 30, 2022 | 97.74 Mn |
| Jun 30, 2022 | 106.69 Mn |
| Mar 31, 2022 | 106.17 Mn |
| Dec 31, 2021 | 119.23 Mn |
API Access
InflaRx Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=IFRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "IFRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=IFRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();